De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Journal article published in 2019 by
V. Guarneri,
M. V. Dieci 
,
G. Bisagni,
A. Frassoldati,
G. V. Bianchi,
G. L. De Salvo,
E. Orvieto,
L. Urso,
T. Pascual ,
L. Paré,
P. Galván ,
M. Ambroggi,
C. A. Giorgi ,
G. Moretti,
G. Griguolo
and other authors.
,
G. Bisagni,
A. Frassoldati,
G. V. Bianchi,
G. L. De Salvo,
E. Orvieto,
L. Urso,
T. Pascual ,
L. Paré,
P. Galván ,
M. Ambroggi,
C. A. Giorgi ,
G. Moretti,
G. Griguolo
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 